Medimix International To Present Paper On Healthcare Politics At PBIRG Annual Convention, May 18-21, Washington, D.C.
As the pharmaceutical marketplace has become increasingly integrated in terms of sales, production, and consumption, the emphasis has shifted from the industrialized nations to the developing World. With international acknowledgement of the impact of HIV/AIDS on the poorest nations, and the recurring threat of diseases that have become drug-resistant, such as malaria, TB, and yellow fever, it has become readily apparent that medicine can become an effective tool of foreign policy.
So all phases, from research to marketing, profits, and safety are of great concern to the policy-makers, and both local and world governments are eager to find ways to regulate the entire process. How do the different governments address regulation within their borders? What factors influence their decisions, and are they looking at the same issues? Access to healthcare is a prime example. Today's strained and often inequitable healthcare systems threaten economic and social instability in some parts of the world. In Europe, health systems are primarily the responsibility of the member states, but several recent rulings of the European Court of Justice confirm that EU citizens can seek healthcare in other member states with the cost being covered by their own health systems! And Eastern Europe struggles with a crumbling system so ridden by corruption that it has ceased to provide even the most rudimentary health services.
Taiwan's system is frequently mentioned for cost-effectiveness and offers comprehensive universal health coverage to 23 million citizens. In China and India, where programs vary from state to state, the individual shoulders more of the financial burden. However, China plans to offer basic health coverage to its entire population by 2010, which in itself carries serious implications for government legislation on patents, cost controls, importation of products, etc.
Other examples of state or country differences:
- Immunization is mandatory in certain countries and not in others.
- In the US, 21 states have passed specific legislation on reporting sharp injuries, 29 others have not.
- Approval procedures at the national Asian (KFDA, SFDA) and European (EMEA) levels differ from US (FDA).
- Patents are not equally recognized in the new EEC countries, but harmonized through the so called "specific mechanism".
- Recognition of the TRIPS will impact Chinese and other Asian Healthcare systems.
- HER's (Health Electronic Records) and legislation to deal with globalization standards and procedures, data and patient confidentiality.
- Genetics laws - in the US fifteen states have laws pertaining to human cloning and some extend prohibitions to therapeutic cloning or cloning for research purposes. In 2005, the UN, after two years of debate, voted to approve a non-binding global ban on all human cloning.
"Presenting this paper at the PBIRG University, especially in Washington DC this election year, is a great opportunity to communicate to various stakeholders about the changes happening in the healthcare environment worldwide. The impact of Asian economies' growth on Healthcare is only at its beginning, and it is now crucial for global pharmaceutical marketers to understand the structural differences between the US, Europe and Asia." explained Henry Gazay, CEO of Medimix International.
bout Medimix International
Medimix International is a dynamic provider of advanced marketing research solutions for the healthcare industry worldwide. Medimix's proprietary panel provides direct access to over 500,000 physicians and healthcare professionals from around the world, making it one of the largest panels in the industry. Medimix specializes in global research. Learn more at http://www.medimix.net.
Medimix International
Medimix internaþionale sã prezinte, pe hârtie de servicii de îngrijire medicalã politicã anualã Convenþia de la PBIRG, mai 18-21, Washington, DC, - Medimix International To Present Paper On Healthcare Politics At PBIRG Annual Convention, May 18-21, Washington, D.C. - articole medicale engleza - startsanatate